Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proto Labs (PRLB) EBITDA (2016 - 2025)

Proto Labs' EBITDA history spans 14 years, with the latest figure at $9.7 million for Q4 2025.

  • For Q4 2025, EBITDA rose 734.57% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $28.2 million, up 69.95%, while the annual FY2025 figure was $28.2 million, 69.95% up from the prior year.
  • EBITDA for Q4 2025 was $9.7 million at Proto Labs, up from $7.1 million in the prior quarter.
  • Across five years, EBITDA topped out at $14.9 million in Q2 2021 and bottomed at -$102.4 million in Q4 2022.
  • The 5-year median for EBITDA is $4.2 million (2024), against an average of -$1.6 million.
  • The largest annual shift saw EBITDA crashed 1297.47% in 2022 before it skyrocketed 995.67% in 2023.
  • A 5-year view of EBITDA shows it stood at $8.6 million in 2021, then plummeted by 1297.47% to -$102.4 million in 2022, then surged by 109.05% to $9.3 million in 2023, then plummeted by 116.58% to -$1.5 million in 2024, then skyrocketed by 734.57% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's EBITDA are $9.7 million (Q4 2025), $7.1 million (Q3 2025), and $6.8 million (Q2 2025).